© 2025 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Cameron Santoro is an associate editor for The Center for Biosimilars®, The American Journal of Managed Care® (AJMC), and AJMC.com.
May 23, 2025
Video
Here are the top 5 biosimilar articles for the week of May 19, 2025.
May 22, 2025
Article
Dose escalations were more frequent with ustekinumab in patients with psoriasis compared with adalimumab and etanercept, highlighting varied outcomes for dose optimization in psoriasis management.
May 16, 2025
Video
Here are the top 5 biosimilar articles for the week of May 12, 2025.
May 15, 2025
Article
Ivo Abraham, PhD, highlights follow-on biologics as a pathway to a more equitable global health care system by reducing costs and expanding treatment access.
May 11, 2025
Video
Elena Wolff-Holz, MD, discussed the approval and benefits of the ustekinumab biosimilar, Yesintek, emphasizing its comparable efficacy and safety to Stelara, and potential for increased patient access due to lower costs, and a possible lower immunogenicity profile.
May 09, 2025
Video
Here are the top 5 biosimilar articles for the week of May 5, 2025.
May 06, 2025
Article
Shreehas P. Tambe, MD, highlighted the significant potential for biosimilars to expand into other disease areas like diabetes, offering crucial cost-saving solutions amid a rising global burden of noncommunicable diseases.
May 02, 2025
Video
Here are the top 5 biosimilar articles for the week of April 28, 2025.
April 28, 2025
Article
Christopher T. Robertson, JD, PhD, reviewed the history and ethical landscape of providing access to drugs before FDA approval, highlighting the crucial role of clinical trials and ethical safeguards at the 2025 Festival of Biologics USA.
April 25, 2025
Article
Sonia T. Oskouei, PharmD, emphasized strategies to streamline regulations and evolve to overcome barriers and expand the availability of cost-effective biosimilar treatments across more therapeutic areas.